| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.30B | 21.26B | 21.73B | 23.00B | 22.64B | 21.38B |
| Gross Profit | 2.86B | 2.50B | 2.26B | 2.29B | 1.91B | 1.97B |
| EBITDA | 1.59B | 1.28B | 1.35B | 1.22B | 880.53M | 777.63M |
| Net Income | 1.11B | 1.06B | 625.55M | 1.12B | 866.61M | 644.07M |
Balance Sheet | ||||||
| Total Assets | 19.93B | 21.42B | 21.98B | 20.82B | 17.49B | 17.11B |
| Cash, Cash Equivalents and Short-Term Investments | 4.08B | 3.81B | 3.92B | 3.36B | 1.32B | 767.21M |
| Total Debt | 1.79B | 1.87B | 1.83B | 1.82B | 1.09B | 1.77B |
| Total Liabilities | 8.63B | 10.78B | 12.06B | 11.09B | 8.51B | 8.94B |
| Stockholders Equity | 11.08B | 10.42B | 9.71B | 9.50B | 8.74B | 8.00B |
Cash Flow | ||||||
| Free Cash Flow | -404.19M | 784.62M | 1.85B | 812.75M | 220.34M | 389.36M |
| Operating Cash Flow | -131.45M | 1.04B | 2.49B | 2.00B | 1.57B | 990.37M |
| Investing Cash Flow | -82.22M | -1.50B | -1.46B | -152.99M | -103.93M | -676.72M |
| Financing Cash Flow | -393.26M | -356.46M | -478.02M | 185.09M | -911.40M | -879.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | HK$9.34B | 5.97 | 15.41% | 3.74% | 0.82% | 2.99% | |
| ― | HK$10.47B | 8.74 | 10.34% | 3.76% | -0.34% | 64.10% | |
| ― | HK$11.02B | 9.97 | 5.60% | 5.44% | -8.24% | -24.53% | |
| ― | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
| ― | HK$1.17B | 16.28 | 3.61% | 1.85% | -8.51% | -68.34% | |
| ― | HK$1.26B | 19.48 | 2.46% | 3.57% | -5.29% | -32.47% | |
| ― | HK$810.88M | ― | -44.61% | ― | -5.79% | -129.73% |
Sinofert Holdings Limited has announced a revision of the annual cap for its continuing connected transactions under the Information System Services Agreement with Sinochem Information. The company anticipates that the fees payable under this agreement for 2025 will exceed the original cap, prompting the board to revise it. This adjustment reflects the company’s ongoing commitment to maintaining robust information system services, which include system operation, maintenance, software licensing, procurement, and artificial intelligence services. The revision is subject to certain reporting and review requirements but does not require independent shareholders’ approval.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$2.00 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings Limited reported a 7.56% increase in revenue to RMB14,715 million and a 5.04% rise in profit to RMB1,104 million for the first half of 2025. Despite global economic challenges and fluctuating fertilizer prices, the company maintained its focus on core responsibilities and business strategies, achieving growth in operational effectiveness and efficiency. The Chinese government’s policies have helped stabilize the domestic fertilizer market, ensuring supply and price stability, despite a significant drop in export volumes.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings Limited has announced the appointment of Ms. Zhang Guangyan as a non-executive director and a member of its audit committee, effective from August 25, 2025. Ms. Zhang brings nearly 30 years of experience in regulatory compliance, corporate governance, and risk management, particularly in the fertilizer sector. Her appointment is expected to strengthen the company’s governance framework and enhance its operational oversight, potentially impacting its market positioning positively.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings Limited has announced the composition of its board of directors, highlighting the roles and functions of each member. The announcement underscores the company’s commitment to strong corporate governance and strategic planning, with a diverse board comprising non-executive, executive, and independent non-executive directors, each serving on various committees to guide the company’s operations and strategic direction.
The most recent analyst rating on (HK:0297) stock is a Buy with a HK$1.50 price target. To see the full list of analyst forecasts on Sinofert Holdings stock, see the HK:0297 Stock Forecast page.
Sinofert Holdings Limited has announced a board meeting scheduled for August 25, 2025, to review and approve the unaudited interim results for the first half of the year and consider the payment of an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.